Rankings
▼
Calendar
JAZZ FY 2014 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena
JAZZ
Jazz Pharmaceuticals plc
$11B
FY 2014 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1.2B
+34.4% YoY
Gross Profit
$1.1B
90.0% margin
Operating Income
$196M
16.7% margin
Net Income
$58M
5.0% margin
EPS (Diluted)
$0.93
Cash Flow
Operating Cash Flow
$406M
Free Cash Flow
$167M
Stock-Based Comp.
$70M
Balance Sheet
Total Assets
$3.3B
Total Liabilities
$2.0B
Stockholders' Equity
$1.4B
Cash & Equivalents
$684M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.2B
$872M
+34.4%
Gross Profit
$1.1B
$770M
+37.0%
Operating Income
$196M
$340M
-42.5%
Net Income
$58M
$216M
-73.0%
← FY 2013
All Quarters
FY 2015 →